Real-world efficacy and safety of omalizumab in chronic spontaneous urticaria: Insights from the Middle East

Background: Chronic spontaneous urticaria (CSU) is a mast cell–mediated condition that can cause significant impairment in quality of life. Second-generation H1-antihistamines are recommended as first-line treatment, but a proportion of patients do not achieve adequate control and require add-on the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shuayb Elkhalifa, MBBS, MRCP, FRCPath, CCT Immunology, Eiman Mahmoud, MD, Fulvio Salvo, MD, Hamad AlHameli, MD, Inmaculada Cerecedo, MD, PhD, Irfan Shafiq, MD, Mohamed Abuzakouk, MD, PhD
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-07-01
Colecção:	Journal of Allergy and Clinical Immunology: Global
Assuntos:	Chronic spontaneous urticaria omalizumab real-world study biologic therapy Middle East Urticaria Control Test
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2772829326000676
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!